Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Time to vent.
Current :
PTSC Market Cap
219,580,000.00

The J2/Arm settlement or award (may?) provide PTSC with about half that value.  Point is, it hasn't happened yet.  If it does not work out favorably for PTSC, how much value would there really be from 400 other infringers if this thing derails?  DP said almost a year ago, that the company was now going to focus on the J3 case.  They have been doing just that.  Let them finish.  If they are successful, the market cap of the company will naturally readjust upwards.
How are you figuring current valuation?
Share
New Message
Please login to post a reply